Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David...
-
Upload
shannon-hall -
Category
Documents
-
view
214 -
download
1
Transcript of Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David...
![Page 1: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/1.jpg)
Neuromodulation for Headache & Craniofacial Pain:
50 Consecutive Cases
Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD
Metro Spinal Clinic, Melbourne
Dr Paul Verrills Musculoskeletal PhysicianMBBS FAFMM GDMM(Hons) MPainMed FIPP
![Page 2: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/2.jpg)
Disclosure StatementNo funds have been received in support of this study
Royalties: NIL
Stock Options: NIL
Teaching – Consultant (adhoc peer-peer)
- St. Jude Medical
- Arthrocare
- Mundipharma
- Medtronic
- Boston Scientific
Research Grant: NIL
Travel Support: NIL
![Page 3: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/3.jpg)
Chronic Craniofacial Pain
Treatment of chronic neuropathic pain in the region of the head, neck and face presents a challenge for pain specialists.
Peripheral nerve field stimulation (PNFS) is evolving as a treatment for neuropathic pain
Increase in the number of cases of PNFS for the craniofacial region since the publication of Richard Weiner’s study in 1999.
![Page 4: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/4.jpg)
Supraorbital Trial
![Page 5: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/5.jpg)
Supraorbital Leads
![Page 6: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/6.jpg)
Right Supraorbital and right vertical occipital leads
![Page 7: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/7.jpg)
Occipital and Supraorbital Leads – Unilateral Chronic Daily headache
Supraorbital
Occipital
![Page 8: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/8.jpg)
Occipital Stimulation - Migraines
![Page 9: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/9.jpg)
PNFS for headache and craniofacial pain: Patient Selection
Chronic Daily Headache / Occipital Neuralgia / ‘Migraine’
Neuropathic or combined somatic (nociceptive) & neuropathic pain component.
Failure to respond to other conservative treatments
Red flags excluded
Psychological clearance
Successful trial phase (eg. >50% pain relief)
Informed consent
![Page 10: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/10.jpg)
PNFS for headache and craniofacial pain: Study Design
Data collected over 4 years
50 consecutive implant patients
Follow up rate of 100%
Assessments
Questionnaires, along with patients’ histories were used to assess
Pain (11-point numerical rating scale)
Analgesic use
Depression (Zung Depression Index)
Disability (Neck Disability Index)
Follow up of mean 10.8 ± 6.5 months (range 1-36 months)
![Page 11: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/11.jpg)
PNFS for headache and craniofacial pain: Decrease in Pain
Average pain reduction of 4.8± 2.4 NRS (p ≤ 0.05)
Average pain relief of 62.6 ± 26.4%
Pain Relief
88% of patients achieved ≥ 25%
76% of patients achieved ≥ 50%
43% of patients achieved ≥ 75%
![Page 12: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/12.jpg)
PNFS for headache and craniofacial pain: High patient satisfaction rate
82% of patients were satisfied with their treatment outcome
61% of patients were either very or completely satisfied
![Page 13: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/13.jpg)
PNFS for headache and craniofacial pain: Reduced Analgesic use
77% of patients reported a reduction in analgesic use
66% of patients reported a moderate to extreme decrease
Reduction in analgesic use inversely correlated with pain relief (r = 0.75, p ≤0.05)
patient satisfaction (r = 0.69, p ≤0.05)
![Page 14: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/14.jpg)
PNFS for headache and craniofacial pain: Reduced Disability (NDI)
80% of patients reported reductions in their disability following implantation (p ≤ 0.05)
Median NDI reduced by 8.2 ± 8.6%
Degree of disability following Implantation
0
20
40
60
80
100
Pre Implant Post Implant
Nec
k D
isab
ilit
y In
dex
(%
)
62.156.7
![Page 15: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/15.jpg)
PNFS for occipital/craniofacial pain: Reduced Depression
70% of patients reported reductions in their depression index following implantation
(p ≤ 0.05)
Median Zung reduced by 9.2 ± 9.9%
Depression following Implantation
0
20
40
60
80
Pre Implant Post Implant
Zu
ng
De
pre
ss
ion
SD
S I
nd
ex
(%
)
55.1
47.0
![Page 16: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/16.jpg)
PNFS for occipital/craniofacial pain: Sustained Pain Relief
Pain relief achieved initially following implantation was
sustained at follow up intervals of ≥12 months.
![Page 17: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/17.jpg)
PNFS for occipital/craniofacial pain: Complications
Two thirds of patients achieved favorable outcomes following reposition and/or re-implantation
Complication No. of Patients
Outcome
Reposition / Re-implant / Replace
Explanted
Hardware Erosion 9 6 3
Lead Infection 2 1 1
Hardware Migration 1 1 -
![Page 18: Neuromodulation for Headache & Craniofacial Pain: 50 Consecutive Cases Paul Verrills MD, David Vivian MD, Bruce Mitchell MD and Adele Barnard PhD Metro.](https://reader035.fdocuments.us/reader035/viewer/2022062716/56649ddc5503460f94ad3275/html5/thumbnails/18.jpg)
PNFS for occipital/craniofacial pain: Summary
Average pain reduction of 4.9± 2.5 VAS (p ≤ 0.05)
Average pain relief of 63.1 ± 27.0%.
Reduced disability, analgesic use and depression was observed following PNFS
Reduction in analgesic use inversely correlated with pain relief and patient
satisfaction
This study demonstrates that this reversible, safe and effective treatment is a
promising pain relief strategy for an otherwise intractable condition.
www.metrospinal.com.au